Globus Medical, Inc. (GMED)
NYSE: GMED · IEX Real-Time Price · USD
53.06
+1.44 (2.79%)
Mar 27, 2024, 4:00 PM EDT - Market closed

Globus Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2009
Net Income
122.87190.17149.19102.29155.21156.47107.35104.34112.7892.49
Upgrade
Depreciation & Amortization
144.7368.2569.8762.8752.7341.6342.0738.7724.0821.75
Upgrade
Share-Based Compensation
52.7432.8130.5927.0726.0921.914.6911.389.647.11
Upgrade
Other Operating Activities
-76.85-112.7626.636.56-62.05-38.36-5.04-6.67-22.5-42.18
Upgrade
Operating Cash Flow
243.5178.47276.27198.79171.98181.64159.06147.82124.0179.17
Upgrade
Operating Cash Flow Growth
36.44%-35.40%38.98%15.59%-5.32%14.20%7.60%19.21%56.63%-15.30%
Upgrade
Capital Expenditures
-78.27-74.05-56.9-63.66-70.75-54.7-51.3-40.91-50.76-24.75
Upgrade
Acquisitions
-296.03-31.44-34.49-33.48-23.8-14.83-29.94-76.07-48.51-36.13
Upgrade
Change in Investments
677.27-4.88-284.55-20.18-45.73-123.51-30.03-45.76-53.78-39.12
Upgrade
Investing Cash Flow
302.97-110.36-375.94-117.32-140.28-193.03-111.28-162.74-153.05-100
Upgrade
Share Issuance / Repurchase
-213.17-102.7863.5-32.3531.0439.3111.745.875.489.74
Upgrade
Other Financing Activities
-18.66-7.19-9.35-6.32-6.6-6.74-10.11-5.4-1.23.21
Upgrade
Financing Cash Flow
-231.82-109.9654.15-38.6624.4432.571.630.474.2812.95
Upgrade
Exchange Rate Effect
2.18-0.75-0.810.87-0.16-0.261.98-1.890.150.19
Upgrade
Net Cash Flow
316.83-42.6-46.3343.6755.9820.9351.39-16.34-24.61-7.7
Upgrade
Free Cash Flow
165.23104.42219.38135.14101.23126.95107.76106.9173.2554.42
Upgrade
Free Cash Flow Growth
58.23%-52.40%62.34%33.50%-20.26%17.81%0.79%45.96%34.60%-22.03%
Upgrade
Free Cash Flow Margin
10.53%10.21%22.90%17.13%12.89%17.81%16.94%18.96%13.45%11.47%
Upgrade
Free Cash Flow Per Share
1.461.042.181.371.021.301.121.120.770.58
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).